.
.
.
.
Coronavirus

Japan begins COVID-19 vaccination drive amid Olympic worries

Published: Updated:

Months after other major economies, Japan began giving the first coronavirus vaccines to front-line health workers Wednesday.

Many are wondering if the campaign will reach enough people, and in time, to save a Summer Olympics already delayed a year by the worst pandemic in a century.

For more coronavirus news, visit our dedicated page.

A big problem as the vaccines roll out — first to medical workers, then the elderly and then, possibly in late spring or early summer, to the rest of the population — are worries about shortages of the imported vaccines Japan relies on, and a long-time reluctance among many Japanese to take vaccines because of fears of relatively-rare side effects that have been played up by the media in the past.

The late rollout will make it impossible to reach so-called “herd immunity” against the virus before the Olympics begin in July, experts say.

The vaccination drive has the support of the government, but there’s widespread wariness, even opposition, among citizens to having the Games at all. About 80 percent of those polled in recent media surveys support cancellation or further postponement of the Olympics because of the virus worries.

Attended by a room full of media, Dr. Kazuhiro Araki, president of Tokyo Medical Center, rolled up his shirtsleeves and got a jab Wednesday, becoming one of the first Japanese to be vaccinated.

“It didn’t hurt at all, and I’m feeling very relieved,” he told reporters while he was being monitored for any allergic reaction. “We now have better protection, and I hope we feel more at ease as we provide medical treatment.”

About 40,000 doctors and nurses considered vulnerable to the virus because they treat COVID-19 patients were in the group getting their first dose starting Wednesday and scheduled to receive their second dose beginning March 10.

Japan lags behind many other countries. The government only gave its first vaccine approval Sunday for the shots developed and supplied by Pfizer Inc.

Japan fell behind their pace because it asked Pfizer to conduct clinical trials with Japanese people, in addition to trials already conducted in six other nations. Japanese officials said this was necessary to address worries in a country with low vaccine confidence.

For all the latest headlines follow our Google News channel online or via the app.

Half of the recipients of the first shots will keep daily records of their condition for seven weeks; that data will be used in a health study meant to inform people worried about the side effects.

Japan, where development of its own vaccines is still in the early stages, must rely on foreign-developed vaccines initially. Supplies of imported vaccines are a major worry because of supply shortages and restrictions in Europe, where many are manufactured.

The first batch of the Pfizer vaccine that arrived Friday is enough to cover the first group of medical workers. The second batch is set for delivery next week.

After the front-line health care workers receiving their vaccines now, inoculations of 3.7 million more health workers will begin in March, followed by about 36 million people aged 65 and older starting in April. People with underlying health issues, as well as caregivers at nursing homes and other facilities, will be next, before the general population receives its turn.

Read more:

Japan’s COVID-19 vaccination roll out hampered by syringe shortage

First batch of COVID-19 vaccines arrive in Japan, courtesy of Pfizer

Tokyo Olympics chief Mori set to resign over sexist remarks